Novotech collaborates with PPC Group

Australia |  News | 0 Comment | 03 Dec, 2019

Novotech and PPC Group (PPC), two leading, Asia-Pacific contract research organisations (CROs), have formed a strategic partnership to meet growing demand for clinical trials in the region....Read more

Vaccitech provides update for its Phase 2 Universal Influenza studies

Australia |  News | 0 Comment | 25 Nov, 2019

Vaccitech Ltd, a clinical-stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases, reports successful recruitment and vaccination for its ...Read more

Indian traditional medicine legacy reaches Australia

Australia |  News | 0 Comment | 25 Nov, 2019

All India Institute of Ayurveda (AIIA) has signed a Memorandum of Understanding with Western Sydney University, Australia at New Delhi, India. The MoU will promote the collaboration in rese...Read more

Imagion Biosystems receives patent from India

Australia |  News | 0 Comment | 14 Nov, 2019

Imagion Biosystems Limited, an Australian company dedicated to improving healthcare through the earlier detection of cancer has been issued patent #320872 from the Government of India Paten...Read more

Spectrum Therapeutics focuses on Real World Evidence research

Australia |  News | 0 Comment | 12 Nov, 2019

Spectrum Therapeutics, the medical division of Canopy Growth Corporation (Canopy Growth), is pleased to announce an Australian first for the company. Spectrum has partnered with Emerald Cli...Read more

Icon Group expands footprint in Asia Pacific

Australia |  News | 0 Comment | 11 Nov, 2019

Icon Group (Icon), Australia’s largest dedicated provider of cancer care has announced the completion of a debt raising totalling SGD $759 million to support the company’s strat...Read more

FIND Collaborates with SpeeDx and QuantuMDx

Australia |  News | 0 Comment | 07 Nov, 2019

Australia based SpeeDx Pty. Ltd. and UK headquartered QuantuMDx Group Ltd. have announced a collaboration with the Foundation for Innovative New Diagnostics (FIND). The global non-profit or...Read more

Icon Group expands cancer care capabilities

Australia |  News | 0 Comment | 04 Nov, 2019

Icon Group, Australia's largest dedicated provider of cancer care, with a growing reach into New Zealand and Asia, has made a purchase order to further improve the ...Read more

Mallinckrodt, Terumo BCT announce UVADEX approval in Australia

Australia |  News | 0 Comment | 01 Nov, 2019

Mallinckrodt plc, a global biopharmaceutical company, and Terumo BCT, a global leader in blood component, therapeutic apheresis and cellular technologies have announced that UVADEX®...Read more

Kazia raises A$4.0 M to progress R&D programs

Australia |  News | 0 Comment | 29 Oct, 2019

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company, on 28 October 2019, announced that the completion of a placement of ten million new fully paid ordinary sha...Read more

Fresenius Medical Care expands services in Western Australia

Australia |  News | 0 Comment | 30 Oct, 2019

Fresenius Medical Care, the world's leading provider of dialysis products and services, has announced the further enhancement of support for home dialysis patients in Western Australia. Ce...Read more

World first clinical trial commences in alcohol use disorder

Australia |  News | 0 Comment | 28 Oct, 2019

A medication currently used to treat insomnia may also be effective in preventing alcohol intake and relapse in alcohol use disorder, according to researchers at the Florey Institute of Neu...Read more

Osteopore gets recognition for innovative healthcare product

Australia |  News | 0 Comment | 24 Oct, 2019

Osteopore, an Australian medical device company that designs and manufactures regenerative implants made via 3D printing, has been highly commended at the prestigious TCT Awards, at th...Read more

NeuClone announces First Human dose of Stelara® (Ustekinumab) Biosimilar candidate

Australia |  News | 0 Comment | 21 Oct, 2019

NeuClone, a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, announced on 17 Oct 2019 that it has commenced dosing of Stelara®...Read more

Celltrion, Juno establish biosimilar partnership

Australia |  News | 0 Comment | 18 Oct, 2019

Celltrion Healthcare Australia (Celltrion) and Juno Pharmaceuticals (Juno) have entered in to a co-marketing partnership, covering the biosimilar products Herzuma (biosimilar trastuzumab), ...Read more

Admedus inks $A36.2M deal for CardioCel And VascuCel Patch biz

Australia |  News | 0 Comment | 15 Oct, 2019

Australia based Admedus Limited announces the sale of its CardioCel® and VascuCel® patch business to U.S based LeMaitre Vascular Inc., for up to $A36.2M ($A22.8M...Read more

George Clinical names Sean Hart as Chief Business Officer

Australia |  News | 0 Comment | 14 Oct, 2019

George Clinical, a global scientifically-driven clinical research organization (CRO) has announced the promotion of Sean Hart to the new role of Chief Business Officer. Hart, who joined Geo...Read more

Immutep receives A$2.5 M R&D tax incentive from French Govt

Australia |  News | 0 Comment | 14 Oct, 2019

Immutep Limited, an Australian biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is pleased to announce that it has received a €1,568,...Read more